News

Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last
Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.
Novo Nordisk Wins Legal Battle To Curb Unsafe Knockoff Versions Of Ozempic, Wegovy
The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
Endpoints News1d
Com­pound­ing phar­ma­cies dealt a blow in fight over end of semaglu­tide short­age
A federal district court in Texas on Thursday denied a request for a preliminary injunction from the Outsourcing Facilities ...
Stocktwits on MSN1d
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions ...
Less expensive Ozempic, Wegovy copies restricted after federal court ruling
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
STAT1d
Court ruling opens door to FDA action against Ozempic compounders
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...
Fierce Pharma1d
US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
‘There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes game-changing $2 billion deal for new obesity d…
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Novo Nordisk's Stellar Wegovy-Fuelled Run of Hiking Sales Guidance Could Be Ending
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
Nasdaq17d
Top Analyst Reports for Procter & Gamble, Novo Nordisk & PepsiCo
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Novo Nordisk A/S (NVO) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks ...
The Motley Fool17d
5 Top Growth Stocks to Buy in the Stock Market Sell-Off
It might seem odd to group Eli Lilly and Novo Nordisk, but these drugmakers have much in common. They've been the leaders in the diabetes drug market for decades, and both are now pioneering the ...